Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study to Assess the Safety, Tolerability and Pharmacokinetics of PV-10 Chemoablation of Cancer Metastatic to the Liver or Hepatocellular Carcinoma Not Amenable to Resection or Transplant

NCT00986661 is registered in ClinicalTrials.gov with Provectus Biopharmaceuticals, Inc. as lead sponsor.

NCT NCT00986661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00986661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study to Assess the Safety, Tolerability and Pharmacokinetics of PV-10 Chemoablation of Cancer Metastatic to the Liver or Hepatocellular Carcinoma Not Amenable to Resection or Transplant
Lead sponsor
Provectus Biopharmaceuticals, Inc.
Phase
Phase 1
Overall status
Unknown status
Start date
October 31, 2009
Completion date
February 28, 2023
Enrollment
78 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cancer metastatic to the liver, hepatocellular carcinoma, metastatic breast cancer, metastatic colon cancer, metastatic colorectal cancer, metastatic lung cancer, metastatic melanoma, metastatic ocular melanoma, metastatic pancreatic cancer, metastatic uveal melanoma